shuangzao anshen

shuangzao anshen (developed as Shuangzao Anshen Granules) is an innovative Class 1.1 traditional Chinese medicine (TCM) developed by Fangsheng Pharmaceutical. It is formulated based on years of clinical practice, combining traditional Mongolian medicine experience with TCM theory. The formula centers on two core herbal ingredients: Semen Ziziphi Spinosae (酸枣仁, Suanzaoren) and Fructus Choerospondiatis (广枣, Guangzao), which give the drug its name ('Shuangzao' or 'Double Jujube'). It is indicated for the treatment of chronic insomnia associated with liver-kidney yin deficiency syndrome. The combination of Semen Ziziphi Spinosae (which nourishes blood and calms the mind) and Fructus Choerospondiatis (which promotes qi circulation and calms the heart) addresses symptoms such as restlessness, difficulty sleeping, frequent dreaming, palpitations, anxiety, dizziness, and tinnitus. In October 2026, the National Medical Products Administration (NMPA) of China approved its clinical trial application.